YY1 downregulation restored the expression of myeloid C/EBP transcription factors and growth factors; increased the availability of RARα, making cells more sensitive to ATRA exposure; and restored apoptosis in AML cell lines. Here, CEBPA is linked to acute myeloid leukemia.